Risk Assessment Specialty Section
|
RASS Home | History of RASS
| Officers
| President’s Message |
| Annual Reports | RASS Awards | Conflict of Interest Recusals for Awards |
| Award Winners | ByLaws  |
Proposed Revised ByLaws Draft | Proposed Revised ByLaws with Tracked Changes 
|
Photo Gallery | Downloads
| Links | Newsletters |
Downloads
Webinar February 8, 2012: Challenges In the Application Of Quantitative Approaches In Risk Assessment: A Case Study With Di-(2-Ethylhexyl)Phthalate
Webinar January 11, 2012: Comprehensive Environmental Assessment of Nanomaterials: A Meta-assessment Approach
Webinar December 14, 2011: Studies with Diesel Exhaust Particulate: Implications for the Potential Human Health Hazards of Nanoparticles
Webinar November 9, 2011: Risk from Multiple Chemicals in Polluted Communities
Webinar October 12, 2011: Estimating the Economic Value of Improved Information for Health Risk Assessment 
Webinar June 8, 2011: Linear Low-Dose Extrapolation for Noncancer Health Effects is the Exception, Not the Rule
Webinar May 11, 2011: The Maximum Cumulative Ratio (MCR): A Tool that Uses Both Exposure and Toxicity Data to Determine when Cumulative Assessments are Most Necessary
Webinar April 13, 2011: OSTP Scientific Integrity Guidance Memo—December 17, 2010
Webinar February 9, 2011: Development of a Quantitative Model Incorporating Key Events in a Hepatotoxic MOA to Predict Tumor Incidence
Webinar January 12, 2011: NexGen Risk Assessment Framework
Teleconference December 8, 2010: Selected Silver Book Highlights and Update on Related Activities
Teleconference November 10, 2010: The Use of PBPK Modeling to Reduce Uncertainty in Risk Assessment: Example of Manganese
Teleconference October 13, 2010: An Integrated Evaluation Strategy for Making Regulatory Decisions: Moving From Data Requirements to Knowledge Requirements
Teleconference September 8, 2010: Improving Prognostic Science for Risk Assessment: Developing Better Biomarkers for Key Clinical Diseases
Teleconference June 30, 2010: Developments & Good Practice in Mode of Action/Human Relevance Anaylsis
Teleconference June 9, 2010: Analyzing Genomic Dose-Response Information to Inform Key Events in a Mode of Action for Carcinogenicity: An Example with Arsenic
Teleconference May 12, 2010: Opportunities for Progress in the Applications of Mechanistic Information in Risk Assessment
Rescheduled Teleconference February 10 presented
on April 14, 2010: Key Events Dose-Response Analysis. Part 2: Application to Nutrients, Pathogenic Microorganisms, and Food Allergens
Teleconference January 13, 2010: Key Events Dose-Response Analysis. Part 1: Conceptual Framework and Application to Chemicals
Teleconference December 9, 2009: Biomonitoring
Equivalents: Derivation Guidelines and Lessons Learned
Teleconference June 10, 2009: Models in Environmental Regulatory Decision-Making—Report of the Committee on Models in the Regulatory Decision Process
Teleconference May 13, 2009: Science and Decisions: Advancing Risk Assessment—Joseph Rodricks and Jonathan Levy
Teleconference April 8, 2009: Approaches for Evaluating the Relevance of Multiroute Exposures in Establishing Guideline Values for Drinking Water Contaminants—Kannan Krishnan and Richard Carrier
Teleconference March 11, 2009: Hormesis: What it Means for Toxicology, the Environment and Public Health
Getting the dose-response wrong: why hormesis became marginalized and the threshold model accepted. 
The road to linearity: why linearity at low doses became the basis for carcinogen risk assessment.
Teleconference February 11, 2009: Predicting Pharmacokinetics in Humans: The Bottom-Up Approach
Teleconference January 14, 2009: State of the Science Workshop: Low Dose-Response Extrapolation for Environmental Health Risk Assessment
Teleconference November 12, 2008: Pb NAAQS Human Health Risk Assessment—Overview of Design and Implementation
Teleconference October 8, 2008: Betraying Paracelsus, Ignoring Newton: A Flaw in the Nanotoxicology Paradigm
Teleconference September 10, 2008: Mutagenic MOA Carcinogens: How Hign is the Burden of Proof?
Teleconference June 11, 2008: The Hamner Institutes Programs related to Implementing Recommendations from "Toxicity Testing in the 21st Century: A Vision and a Strategy"
Teleconference May 14, 2008: Incorporating Gene-Environment Information into Kinetic Models: Lessons Learned and Future Challenges
Design and Dose Selection for Chronic Rodent Studies
Integration of Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling of Arsenic to Inform the Risk Assessment Process
Toxicity Testing in the 21st Centry—Mel Andersen and Dan Krewski
Updated Principles for Risk Analysis—Nancy Beck
Integrating Life Stage Susceptibility into Immuntoxicity and Microbial Risk Assessment—Robert W. Luebke
The Unc Atmospheric Simulation Chamber Toxicology System–Effects of Chemical Transformations in Complex Mixtures—Harvey Jeffries, Kenneth G. Sexton, Seth Ebersviller, Kim de Bruijne, Erin Potts, Liz Naess —32 mb, 2–5 minutes to download)
Model Averaging: Beyond Model Uncertainty in Risk Analysis—Matthew W. Wheeler
Developing Tumor-Associated Somatic Mutations as Biomarkers of Cancer Risk—Barbara Parsons
Benchmark Dose Evaluations for Acute Inhalation Exposures to Human Toxicants—G.V. Alexeeff, K. K. Deng, R. L. Broadwin, A. G. Salmon
Framework for Inorganic Metals Risk Assessment—Anne Fairbrother, Randy Wentsel, Bill Wood, Keith Sappington, and Pam Noyes Office of Research and Development
The Application of Genomic Dose-Response Data in Risk Assessment—Harvey Clewell and Rusty Thomas CIIT Centers for Health Research
Use of Developmental Neurotoxicity Data in Risk Assessment at EPA: Current Status and Future Efforts—Kathleen Raffaele and William Mundy
A Biologically-Based Model for Low-Dose Extrapolation of Cancer Risk from Ionizing Radiation—Doug Crawford-Brown
Dosimetry Can Change
Mechanistic Models: The Challenge of Scrutinizing the Source Before Gathering and Analyzing the Data—Owen R. Moss
Dose-Response Modeling for EPA’s Organophosphate Cumulative
Risk Assessment: Combining Information from Several Datasets to Estimate Relative Potency Factors—R. Woodrow Setzer
Dose-Response Modeling: Past, Present, and Future: Rory B.
Conolly
Intentional Human Dosing Studies for EPA: SOT Briefing
Dose-Response Modeling: Past, Present, and Future II:—Rory B. Conolly and Rusty Thomas
HESI Project Committee on Dose-Dependent Transitions in Mechanisms of Toxicity Teleconference: Part 1 of 3
HESI Project Committee on Dose-Dependent Transitions in Mechanisms of Toxicity Teleconference: Part 2 of 3
HESI Project Committee on Dose-Dependent Transitions in Mechanisms of Toxicity Teleconference: Part 3 of 3
Identifying Research Needs for Risk Assessment of U.S. Food Supply
Security–Bruce Hope
RASS Annual Business Meeting & Reception
RASS Reception HESI Panel
RASS Panel Discussion Questions
Assessing the Real Risk in Complex Diseases—Michael N.
Liebman
|
